| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 136, 1544-1548, Copyright © 1995 by Endocrine Society
ARTICLES |
T Imai, Y Hirata, M Iwashina and F Marumo
Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.
Adrenomedullin (AM), a novel vasodilatory peptide originally isolated from human pheochromocytoma, has subsequently been shown to be expressed in a variety of tissues, such as adrenal gland, lung, heart, kidney, and aorta. To determine whether vascular AM gene expression is under hormonal control, the effects of dexamethasone (DEX) and T3 on AM messenger RNA (mRNA) expression were tested in cultured rat vascular endothelial cells and smooth muscle cells (VSMCs) by Northern blot analysis using polymerase chain reaction-cloned rat AM complementary DNA as a probe. DEX dose and time dependently increased steady-state AM mRNA levels in both endothelial cells and VSMC. T3 modestly induced AM mRNA expression in both cells, whereas rT3, a biologically inactive isomer of T3, failed to affect AM mRNA expression. A glucocorticoid receptor antagonist (RU 38486) blocked DEX-induced AM mRNA expression in both cells, whereas neither estradiol nor testosterone affected AM mRNA expression. Actinomycin D abolished basal as well as stimulated AM mRNA expression by T3, whereas cycloheximide markedly increased steady state mRNA levels (superinduction). The approximate half-lives of basal and stimulated expression of AM mRNA by DEX in VSMC were within 1 h. In contrast, there was little, if any, decay in cycloheximide-induced AM mRNA expression over 6 h. Our study demonstrates that the AM gene expressed by vascular endothelial and smooth muscle cells is similarly regulated by glucocorticoid and possibly by thyroid hormone, and that superinduction of AM mRNA is most likely due to increased mRNA stability.
This article has been cited by other articles:
![]() |
T. Otto and J. Fandrey Thyroid Hormone Induces Hypoxia-Inducible Factor 1{alpha} Gene Expression through Thyroid Hormone Receptor {beta}/Retinoid X Receptor {alpha}-Dependent Activation of Hepatic Leukemia Factor Endocrinology, May 1, 2008; 149(5): 2241 - 2250. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Klein and S. Danzi Thyroid Disease and the Heart Circulation, October 9, 2007; 116(15): 1725 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J Pearson, C. Rait, M G. Nicholls, T. G Yandle, and J. J Evans Regulation of adrenomedullin release from human endothelial cells by sex steroids and angiotensin-II. J. Endocrinol., October 1, 2006; 191(1): 171 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ma, P. Freitag, J. Zhou, B. Brune, S. Frede, and J. Fandrey Thyroid hormone induces erythropoietin gene expression through augmented accumulation of hypoxia-inducible factor-1 Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R600 - R607. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Hinson, S. Kapas, and D. M. Smith Adrenomedullin, a Multifunctional Regulatory Peptide Endocr. Rev., April 1, 2000; 21(2): 138 - 167. [Abstract] [Full Text] |
||||
![]() |
E. B. Pewitt, R. Haleem, and Z. Wang Adrenomedullin Gene Is Abundantly Expressed and Directly Regulated by Androgen in the Rat Ventral Prostate Endocrinology, May 1, 1999; 140(5): 2382 - 2386. [Abstract] [Full Text] |
||||
![]() |
B. Geny, G. Brandenberger, J. Lonsdorfer, N. Chakfe, P. Haberey, and F. Piquard Circulating adrenomedullin is increased after heart transplantation Cardiovasc Res, March 1, 1999; 41(3): 731 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Iwasaki, S. Eguchi, M. Shichiri, F. Marumo, and Y. Hirata Adrenomedullin as a Novel Growth-Promoting Factor for Cultured Vascular Smooth Muscle Cells: Role of Tyrosine Kinase-Mediated Mitogen-Activated Protein Kinase Activation Endocrinology, August 1, 1998; 139(8): 3432 - 3441. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Isumi, H. Shoji, S. Sugo, T. Tochimoto, M. Yoshioka, K. Kangawa, H. Matsuo, and N. Minamino Regulation of Adrenomedullin Production in Rat Endothelial Cells Endocrinology, March 1, 1998; 139(3): 838 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Meeran, D. O'Shea, P. D. Upton, C. J. Small, M. A. Ghatei, P. H. Byfield, and S. R. Bloom Circulating Adrenomedullin Does Not Regulate Systemic Blood Pressure but Increases Plasma Prolactin after Intravenous Infusion in Humans: A Pharmacokinetic Study J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 95 - 100. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |